| Autor: |
Tacket CO; Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore St., Baltimore, MD 21201, USA. ctacket@medicine.umaryland.edu |
| Jazyk: |
angličtina |
| Zdroj: |
Current topics in microbiology and immunology [Curr Top Microbiol Immunol] 2009; Vol. 332, pp. 103-17. |
| DOI: |
10.1007/978-3-540-70868-1_6 |
| Abstrakt: |
Vaccines consisting of transgenic plant-derived antigens offer a new strategy for development of safe, inexpensive vaccines. The vaccine antigens can be eaten with the edible part of the plant or purified from plant material. In phase 1 clinical studies of prototype potato- and corn-based vaccines, these vaccines have been safe and immunogenic without the need for a buffer or vehicle other than the plant cell. Transgenic plant technology is attractive for vaccine development because these vaccines are needle-less, stable, and easy to administer. This chapter examines some early human studies of oral transgenic plant-derived vaccines against enterotoxigenic Escherichia coli infection, norovirus, and hepatitis B. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
